Results in the Treatment of Cancer of the Breast by Interstitial Irradiation of the Pituitary
1960

Pituitary Irradiation for Breast Cancer

Sample size: 100 publication Evidence: low

Author Information

Author(s): W. P. Greening, G. S. Ramsay, J. J. Stevenson, E. Boyland, P. C. Rigby-Jones, B. Godsmark

Primary Institution: Royal Marsden Hospital

Hypothesis

Can interstitial irradiation of the pituitary improve outcomes in patients with advanced breast cancer?

Conclusion

The study found that interstitial irradiation of the pituitary had a low remission rate and significant complications, but may still be useful in certain cases.

Supporting Evidence

  • Only two patients are alive after treatment, with a low overall remission rate of 12%.
  • The average survival after treatment was 19.4 months.
  • Complications included headache, diabetes insipidus, and meningitis, leading to 10 deaths.

Takeaway

Doctors tried a new way to treat breast cancer by using radiation on the pituitary gland, but it didn't help most patients and caused some serious problems.

Methodology

Patients with advanced breast cancer were treated with either gold-198 or yttrium-90 isotopes implanted in the pituitary gland.

Potential Biases

Selection bias may exist as only patients who had failed previous treatments were included.

Limitations

The study included patients who had already undergone other treatments, making it difficult to assess the effectiveness of this method alone.

Participant Demographics

Patients with advanced breast cancer, previously treated with other methods.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication